Portal Hypertension
The normal liver offers little resistance to portal venous blood flow (about 1 L/min), and portal pressure is normally less than 5 mm Hg above inferior vena caval pressure. The distortion of hepatic architecture in cirrhosis leads to a marked increase in resistance to portal venous flow, which in turn leads to an increase in portal venous pressure.
Although cirrhosis is the most important cause of portal hypertension, any process leading to increased resistance to portal blood flow into or through the liver or to hepatic venous outflow from the liver will result in portal hypertension . Since the pressure within any vascular system is proportional to both resistance and blood flow, a marked increase in blood flow will also result in portal hypertension, although such situations are rare.
Portal hypertension leads to the formation of venous collaterals between the portal and systemic circulations. Collaterals may form at several sites, the most important clinically being those connecting the portal to the azygos vein which form dilated, tortuous veins (varices) in the sub-mucosa of the gastric fundus and esophagus.
Variceal Hemorrhage. Hemorrhage occurs most frequently from varices in the esophagus and is a common and serious complication of portal hypertension, with a mortality rate of 30 to 60 per cent. What leads to variceal rupture is unknown, but reflux esophagitis and the presence of ascites do not appear to be important. Bleeding may present as hematemesis, hematochezia, melena, or any combination of these . Bleeding may lead to shock, stop spontaneously, or recur.
- GROSS ANATOMY
- ANTIBIOTICS
- Nephrogenic Diabetes Insipidus (NDI)
- HYPERKINETIC PULMONARY HYPERTENSION
- APPROACH TO THE PATIENT WJTH SUSPECTED MALDIGESTION AND/OR MALABSORPTION
- Hematopoietic System
- ATHEROSCLEROSIS
- DEFINITION
- Regulation of Fluids and Electrolytes
- Women’s Health Program
- EMPHYSEMA
- PHYSICAL THERAPY AND REHABILITATION
- MYOCARDIAL DISEASE - MYOCARDITIS
- VASCULAR DISEASE OF THE LIVER
- HEMODIALYSIS AND HEMOPERFUSION IN THE TREATMENT OF DRUG OVERDOSES
- Initial Assessment
- Proliferative Glomerulonephritis
- DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
- NORMAL INTESTINAL PHYSIOLOGY
- Endocrine and Other Considerations
- Clinical Manifestations
- Visualization of the Biliary Tree
- DEFINITION
- GRANULOMATOUS LIVER DISEASE
- GENERAL SURGERY IN THE PATIENT WITH HEART DISEASE
- Urolithiasis
- CLINICAL ASSESSMENT OF THE REGULATION OF VENTILATION
- Lower GI Bleeding
- PULMONARY GAS EXCHANGE
- Genitourinary System
- Treatment
- VENTILATION
- Uremic Osteodystrophy
- THE ZOLLINGER-ELLISON SYNDROME
- NONPENETRATING TRAUMA